Global Benign Prostatic Hypertrophy Implant Devices Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Benign Prostatic Hypertrophy Implant Devices Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Benign Prostatic Hypertrophy Implant Devices by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Benign Prostatic Hypertrophy Implant Devices by Country/Region, 2017, 2022 & 2028

2.2 Benign Prostatic Hypertrophy Implant Devices Segment by Type

2.2.1 Temporary

2.2.2 Long-term

2.3 Benign Prostatic Hypertrophy Implant Devices Sales by Type

2.3.1 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2017-2022)

2.3.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue and Market Share by Type (2017-2022)

2.3.3 Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Type (2017-2022)

2.4 Benign Prostatic Hypertrophy Implant Devices Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Other

2.5 Benign Prostatic Hypertrophy Implant Devices Sales by Application

2.5.1 Global Benign Prostatic Hypertrophy Implant Devices Sale Market Share by Application (2017-2022)

2.5.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue and Market Share by Application (2017-2022)

2.5.3 Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Application (2017-2022)

3 Global Benign Prostatic Hypertrophy Implant Devices by Company

3.1 Global Benign Prostatic Hypertrophy Implant Devices Breakdown Data by Company

3.1.1 Global Benign Prostatic Hypertrophy Implant Devices Annual Sales by Company (2020-2022)

3.1.2 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Company (2020-2022)

3.2 Global Benign Prostatic Hypertrophy Implant Devices Annual Revenue by Company (2020-2022)

3.2.1 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Company (2020-2022)

3.2.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Company (2020-2022)

3.3 Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Company

3.4 Key Manufacturers Benign Prostatic Hypertrophy Implant Devices Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Benign Prostatic Hypertrophy Implant Devices Product Location Distribution

3.4.2 Players Benign Prostatic Hypertrophy Implant Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Benign Prostatic Hypertrophy Implant Devices by Geographic Region

4.1 World Historic Benign Prostatic Hypertrophy Implant Devices Market Size by Geographic Region (2017-2022)

4.1.1 Global Benign Prostatic Hypertrophy Implant Devices Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Benign Prostatic Hypertrophy Implant Devices Annual Revenue by Geographic Region

4.2 World Historic Benign Prostatic Hypertrophy Implant Devices Market Size by Country/Region (2017-2022)

4.2.1 Global Benign Prostatic Hypertrophy Implant Devices Annual Sales by Country/Region (2017-2022)

4.2.2 Global Benign Prostatic Hypertrophy Implant Devices Annual Revenue by Country/Region

4.3 Americas Benign Prostatic Hypertrophy Implant Devices Sales Growth

4.4 APAC Benign Prostatic Hypertrophy Implant Devices Sales Growth

4.5 Europe Benign Prostatic Hypertrophy Implant Devices Sales Growth

4.6 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Growth

5 Americas

5.1 Americas Benign Prostatic Hypertrophy Implant Devices Sales by Country

5.1.1 Americas Benign Prostatic Hypertrophy Implant Devices Sales by Country (2017-2022)

5.1.2 Americas Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2017-2022)

5.2 Americas Benign Prostatic Hypertrophy Implant Devices Sales by Type

5.3 Americas Benign Prostatic Hypertrophy Implant Devices Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Benign Prostatic Hypertrophy Implant Devices Sales by Region

6.1.1 APAC Benign Prostatic Hypertrophy Implant Devices Sales by Region (2017-2022)

6.1.2 APAC Benign Prostatic Hypertrophy Implant Devices Revenue by Region (2017-2022)

6.2 APAC Benign Prostatic Hypertrophy Implant Devices Sales by Type

6.3 APAC Benign Prostatic Hypertrophy Implant Devices Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Benign Prostatic Hypertrophy Implant Devices by Country

7.1.1 Europe Benign Prostatic Hypertrophy Implant Devices Sales by Country (2017-2022)

7.1.2 Europe Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2017-2022)

7.2 Europe Benign Prostatic Hypertrophy Implant Devices Sales by Type

7.3 Europe Benign Prostatic Hypertrophy Implant Devices Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices by Country

8.1.1 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Country (2017-2022)

8.1.2 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2017-2022)

8.2 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Type

8.3 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Benign Prostatic Hypertrophy Implant Devices

10.3 Manufacturing Process Analysis of Benign Prostatic Hypertrophy Implant Devices

10.4 Industry Chain Structure of Benign Prostatic Hypertrophy Implant Devices

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Benign Prostatic Hypertrophy Implant Devices Distributors

11.3 Benign Prostatic Hypertrophy Implant Devices Customer

12 World Forecast Review for Benign Prostatic Hypertrophy Implant Devices by Geographic Region

12.1 Global Benign Prostatic Hypertrophy Implant Devices Market Size Forecast by Region

12.1.1 Global Benign Prostatic Hypertrophy Implant Devices Forecast by Region (2023-2028)

12.1.2 Global Benign Prostatic Hypertrophy Implant Devices Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Benign Prostatic Hypertrophy Implant Devices Forecast by Type

12.7 Global Benign Prostatic Hypertrophy Implant Devices Forecast by Application

13 Key Players Analysis

13.1 Olympus Medical

13.1.1 Olympus Medical Company Information

13.1.2 Olympus Medical Benign Prostatic Hypertrophy Implant Devices Product Offered

13.1.3 Olympus Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Olympus Medical Main Business Overview

13.1.5 Olympus Medical Latest Developments

13.2 Butterfly Medical

13.2.1 Butterfly Medical Company Information

13.2.2 Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Product Offered

13.2.3 Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Butterfly Medical Main Business Overview

13.2.5 Butterfly Medical Latest Developments

13.3 SRS Medical

13.3.1 SRS Medical Company Information

13.3.2 SRS Medical Benign Prostatic Hypertrophy Implant Devices Product Offered

13.3.3 SRS Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 SRS Medical Main Business Overview

13.3.5 SRS Medical Latest Developments

13.4 Teleflex Interventional Urology

13.4.1 Teleflex Interventional Urology Company Information

13.4.2 Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Product Offered

13.4.3 Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Teleflex Interventional Urology Main Business Overview

13.4.5 Teleflex Interventional Urology Latest Developments

13.5 Urotronic

13.5.1 Urotronic Company Information

13.5.2 Urotronic Benign Prostatic Hypertrophy Implant Devices Product Offered

13.5.3 Urotronic Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Urotronic Main Business Overview

13.5.5 Urotronic Latest Developments

13.6 Zenflow

13.6.1 Zenflow Company Information

13.6.2 Zenflow Benign Prostatic Hypertrophy Implant Devices Product Offered

13.6.3 Zenflow Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Zenflow Main Business Overview

13.6.5 Zenflow Latest Developments

13.7 ProArc Medical

13.7.1 ProArc Medical Company Information

13.7.2 ProArc Medical Benign Prostatic Hypertrophy Implant Devices Product Offered

13.7.3 ProArc Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 ProArc Medical Main Business Overview

13.7.5 ProArc Medical Latest Developments

13.8 Medeon Biodesign

13.8.1 Medeon Biodesign Company Information

13.8.2 Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Product Offered

13.8.3 Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Medeon Biodesign Main Business Overview

13.8.5 Medeon Biodesign Latest Developments

14 Research Findings and Conclusion

Table 1. Benign Prostatic Hypertrophy Implant Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Benign Prostatic Hypertrophy Implant Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Temporary

Table 4. Major Players of Long-term

Table 5. Global Benign Prostatic Hypertrophy Implant Devices Sales by Type (2017-2022) & (Units)

Table 6. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2017-2022)

Table 7. Global Benign Prostatic Hypertrophy Implant Devices Revenue by Type (2017-2022) & ($ million)

Table 8. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Type (2017-2022)

Table 9. Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Benign Prostatic Hypertrophy Implant Devices Sales by Application (2017-2022) & (Units)

Table 11. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2017-2022)

Table 12. Global Benign Prostatic Hypertrophy Implant Devices Revenue by Application (2017-2022)

Table 13. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Application (2017-2022)

Table 14. Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Benign Prostatic Hypertrophy Implant Devices Sales by Company (2020-2022) & (Units)

Table 16. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Company (2020-2022)

Table 17. Global Benign Prostatic Hypertrophy Implant Devices Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Company (2020-2022)

Table 19. Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Benign Prostatic Hypertrophy Implant Devices Producing Area Distribution and Sales Area

Table 21. Players Benign Prostatic Hypertrophy Implant Devices Products Offered

Table 22. Benign Prostatic Hypertrophy Implant Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Benign Prostatic Hypertrophy Implant Devices Sales by Geographic Region (2017-2022) & (Units)

Table 26. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share Geographic Region (2017-2022)

Table 27. Global Benign Prostatic Hypertrophy Implant Devices Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Benign Prostatic Hypertrophy Implant Devices Sales by Country/Region (2017-2022) & (Units)

Table 30. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country/Region (2017-2022)

Table 31. Global Benign Prostatic Hypertrophy Implant Devices Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Benign Prostatic Hypertrophy Implant Devices Sales by Country (2017-2022) & (Units)

Table 34. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2017-2022)

Table 35. Americas Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2017-2022)

Table 37. Americas Benign Prostatic Hypertrophy Implant Devices Sales by Type (2017-2022) & (Units)

Table 38. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2017-2022)

Table 39. Americas Benign Prostatic Hypertrophy Implant Devices Sales by Application (2017-2022) & (Units)

Table 40. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2017-2022)

Table 41. APAC Benign Prostatic Hypertrophy Implant Devices Sales by Region (2017-2022) & (Units)

Table 42. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region (2017-2022)

Table 43. APAC Benign Prostatic Hypertrophy Implant Devices Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Region (2017-2022)

Table 45. APAC Benign Prostatic Hypertrophy Implant Devices Sales by Type (2017-2022) & (Units)

Table 46. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2017-2022)

Table 47. APAC Benign Prostatic Hypertrophy Implant Devices Sales by Application (2017-2022) & (Units)

Table 48. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2017-2022)

Table 49. Europe Benign Prostatic Hypertrophy Implant Devices Sales by Country (2017-2022) & (Units)

Table 50. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2017-2022)

Table 51. Europe Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2017-2022)

Table 53. Europe Benign Prostatic Hypertrophy Implant Devices Sales by Type (2017-2022) & (Units)

Table 54. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2017-2022)

Table 55. Europe Benign Prostatic Hypertrophy Implant Devices Sales by Application (2017-2022) & (Units)

Table 56. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Country (2017-2022) & (Units)

Table 58. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Type (2017-2022) & (Units)

Table 62. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Application (2017-2022) & (Units)

Table 64. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Benign Prostatic Hypertrophy Implant Devices

Table 66. Key Market Challenges & Risks of Benign Prostatic Hypertrophy Implant Devices

Table 67. Key Industry Trends of Benign Prostatic Hypertrophy Implant Devices

Table 68. Benign Prostatic Hypertrophy Implant Devices Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Benign Prostatic Hypertrophy Implant Devices Distributors List

Table 71. Benign Prostatic Hypertrophy Implant Devices Customer List

Table 72. Global Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Region (2023-2028) & (Units)

Table 73. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Forecast by Region

Table 74. Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Country (2023-2028) & (Units)

Table 77. Americas Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Region (2023-2028) & (Units)

Table 79. APAC Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Country (2023-2028) & (Units)

Table 81. Europe Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Country (2023-2028) & (Units)

Table 83. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Type (2023-2028) & (Units)

Table 85. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Application (2023-2028) & (Units)

Table 89. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share Forecast by Application (2023-2028)

Table 92. Olympus Medical Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors

Table 93. Olympus Medical Benign Prostatic Hypertrophy Implant Devices Product Offered

Table 94. Olympus Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Olympus Medical Main Business

Table 96. Olympus Medical Latest Developments

Table 97. Butterfly Medical Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors

Table 98. Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Product Offered

Table 99. Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Butterfly Medical Main Business

Table 101. Butterfly Medical Latest Developments

Table 102. SRS Medical Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors

Table 103. SRS Medical Benign Prostatic Hypertrophy Implant Devices Product Offered

Table 104. SRS Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. SRS Medical Main Business

Table 106. SRS Medical Latest Developments

Table 107. Teleflex Interventional Urology Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors

Table 108. Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Product Offered

Table 109. Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Teleflex Interventional Urology Main Business

Table 111. Teleflex Interventional Urology Latest Developments

Table 112. Urotronic Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors

Table 113. Urotronic Benign Prostatic Hypertrophy Implant Devices Product Offered

Table 114. Urotronic Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Urotronic Main Business

Table 116. Urotronic Latest Developments

Table 117. Zenflow Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors

Table 118. Zenflow Benign Prostatic Hypertrophy Implant Devices Product Offered

Table 119. Zenflow Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Zenflow Main Business

Table 121. Zenflow Latest Developments

Table 122. ProArc Medical Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors

Table 123. ProArc Medical Benign Prostatic Hypertrophy Implant Devices Product Offered

Table 124. ProArc Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. ProArc Medical Main Business

Table 126. ProArc Medical Latest Developments

Table 127. Medeon Biodesign Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors

Table 128. Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Product Offered

Table 129. Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Medeon Biodesign Main Business

Table 131. Medeon Biodesign Latest Developments

List of Figures

Figure 1. Picture of Benign Prostatic Hypertrophy Implant Devices

Figure 2. Benign Prostatic Hypertrophy Implant Devices Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Benign Prostatic Hypertrophy Implant Devices Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Benign Prostatic Hypertrophy Implant Devices Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Temporary

Figure 10. Product Picture of Long-term

Figure 11. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type in 2021

Figure 12. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Type (2017-2022)

Figure 13. Benign Prostatic Hypertrophy Implant Devices Consumed in Hospital

Figure 14. Global Benign Prostatic Hypertrophy Implant Devices Market: Hospital (2017-2022) & (Units)

Figure 15. Benign Prostatic Hypertrophy Implant Devices Consumed in Clinic

Figure 16. Global Benign Prostatic Hypertrophy Implant Devices Market: Clinic (2017-2022) & (Units)

Figure 17. Benign Prostatic Hypertrophy Implant Devices Consumed in Other

Figure 18. Global Benign Prostatic Hypertrophy Implant Devices Market: Other (2017-2022) & (Units)

Figure 19. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2017-2022)

Figure 20. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Application in 2021

Figure 21. Benign Prostatic Hypertrophy Implant Devices Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Company in 2021

Figure 23. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Geographic Region in 2021

Figure 25. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region (2017-2022)

Figure 26. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country/Region in 2021

Figure 27. Americas Benign Prostatic Hypertrophy Implant Devices Sales 2017-2022 (Units)

Figure 28. Americas Benign Prostatic Hypertrophy Implant Devices Revenue 2017-2022 ($ Millions)

Figure 29. APAC Benign Prostatic Hypertrophy Implant Devices Sales 2017-2022 (Units)

Figure 30. APAC Benign Prostatic Hypertrophy Implant Devices Revenue 2017-2022 ($ Millions)

Figure 31. Europe Benign Prostatic Hypertrophy Implant Devices Sales 2017-2022 (Units)

Figure 32. Europe Benign Prostatic Hypertrophy Implant Devices Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales 2017-2022 (Units)

Figure 34. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue 2017-2022 ($ Millions)

Figure 35. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country in 2021

Figure 36. Americas Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country in 2021

Figure 37. United States Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region in 2021

Figure 42. APAC Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Regions in 2021

Figure 43. China Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country in 2021

Figure 50. Europe Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country in 2021

Figure 51. Germany Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country in 2021

Figure 58. Egypt Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Benign Prostatic Hypertrophy Implant Devices in 2021

Figure 64. Manufacturing Process Analysis of Benign Prostatic Hypertrophy Implant Devices

Figure 65. Industry Chain Structure of Benign Prostatic Hypertrophy Implant Devices

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles